Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06176079
What this trial is testing

Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNon Alcoholic Steatohepatitis+2 more
Michael Ohliger, MD PhD 44
Not applicableUnknownNCT06266559
What this trial is testing

Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Chang Gung Memorial Hospital 60
Testing effectiveness (Phase 2)UnknownNCT05941910
What this trial is testing

The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Attikon Hospital 60
Large-scale testing (Phase 3)Study completedNCT04197479
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 1,343
Not applicableNot Yet RecruitingNCT02933554
What this trial is testing

Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis

Who this might be right for
ObesityWeight LossBody Weight+3 more
Keith Pereira, MD: 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05464784
What this trial is testing

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Who this might be right for
Diabetes Mellitus, Type 2HypertriglyceridemiaNon-Alcoholic Fatty Liver Disease
MediciNova 40
Post-approval studies (Phase 4)Study completedNCT03068065
What this trial is testing

Antidiabetic Effects on Intrahepatic Fat

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Not applicableLooking for participantsNCT07246421
What this trial is testing

Glucagon Resistance in Patients With MASLD and T2DM

Who this might be right for
Metabolic Associated Fatty Liver DiseaseType 2 Diabetes (T2DM)
University of Aarhus 24
Testing effectiveness (Phase 2)Study completedNCT05254626
What this trial is testing

Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Cairo University 100
Early research (Phase 1)Study completedNCT05897606
What this trial is testing

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Sulaimani Polytechnic University 160
Not applicableEnded earlyNCT01260246
What this trial is testing

Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNonalcoholic Steatohepatitis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 12
Not applicableStudy completedNCT06491342
What this trial is testing

Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver, Nonalcoholic
Phramongkutklao College of Medicine and Hospital 90
Large-scale testing (Phase 3)UnknownNCT03970031
What this trial is testing

MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

Who this might be right for
Type2 DiabetesNASH - Nonalcoholic SteatohepatitisNonalcoholic Steatohepatitis+1 more
Cirius Therapeutics, Inc. 1,800
Not applicableUnknownNCT04335396
What this trial is testing

Screening Patients With Diabetes Mellitus for the Presence of Skin Disorder of Scleredema

Who this might be right for
Diabetes MellitusDiabetes ComplicationsScleroderma-Like Changes+1 more
University of Pecs 150
Not applicableStudy completedNCT07730905
What this trial is testing

Analysis of Renal Impairment Characteristics and High-Risk Factors in Chronic Hepatitis B Patients on Long-Term Oral Nucleos(t)Ide Analogues

Who this might be right for
Non-alcoholic Fatty Liver Disease, Renal Function Impairment
Foshan Hospital of Traditional Chinese Medicine 300
Testing effectiveness (Phase 2)Study completedNCT04773964
What this trial is testing

Study to Evaluate MET642 in Patients With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Metacrine, Inc. 215
Testing effectiveness (Phase 2)Study completedNCT01571063
What this trial is testing

Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
University of Zurich 22
Not applicableUnknownNCT05106049
What this trial is testing

Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Assiut University 90
Post-approval studies (Phase 4)Study completedNCT03434613
What this trial is testing

Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseDyslipidemias
Yonsei University 64
Testing effectiveness (Phase 2)Study completedNCT03166735
What this trial is testing

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
Boehringer Ingelheim 114
Next Page